Shivering.
Conditions
Interventions
Intervention 1: Intervention group A: informed consent from patients first. After patients are placed on operating room bed, standard monitoring including pulse oximeter, barometer, ECG and baseline v
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women in the age range18-45 2- Anesthesiologists American Society of (ASA)) degree2and3 candidate for cesarean section Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: A history of hypersensivity to alpha adrenergic drug Liver Patients Bradycardy history 2nd or 3nd degree AV block Vascular problems Type 2 diabetes Hyopvolemia Taking vasodilator or medications that change the body's central temperature Drug use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shivering. Timepoint: Recovery Duration. Method of measurement: Using the Grassi and Mahajan criterion.;Central temprature. Timepoint: At he base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Tympanic thermometer.;Temperature of Peripheral. Timepoint: At he base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Thermometer Skin.;The level of sedation. Timepoint: At the base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Using the Ramsay Sedation Scale.;Severity of Pain. Timepoint: At of recovery. the base time; after the procedure and then every 15 minutes until discharge. Method of measurement: Using the Visual Analogue Scale.;Systolic blood pressure. Timepoint: At the base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Non invasive blood pressure measurement.;Diastolic blood pressure. Timepoint: At the base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Non invasive blood pressure measurement.;Oxygen saturation. Timepoint: At the base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Pulse oximetry device.;Heart Rate. Timepoint: At the base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Heart monitoring device.;Mean Arterial Blood Pressure. Timepoint: At the base time; after the procedure and then every 15 minutes until discharge of recovery. Method of measurement: Non invasive blood pressure measurement.;Duration of stay in recovery. Timepoint: From recovery admission to recovery discharge. Method of measurement: Watch or clock. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: Duration of stay in recovery. Method of measurement: Questionnaire.;Vomiting. Timepoint: Duration of stay in recovery. Method of measurement: Questionnaire.;Itching. Timepoint: Duration of stay in recovery. Method of measurement: Questionnaire.;Usage of Atropine. Timepoint: From the beginning of the opration to the end of recovery. Method of measurement: Anesthesia Technician Asked About Drug Use.;Usage of Pethidine. Timepoint: Duration of stay in recovery. Method of measurement: Anesthesia Technician Asked About Drug Use.;Usage of Ephedrine. Timepoint: From the beginning of the opration to the end of recovery. Method of measurement: Anesthesia Technician Asked About Drug Use. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Heydari
Esfahan University of Medical Sciences
Outcome results
None listed